Zongbi Q. Yi
Hubei Key Laboratory Of Tumor Biological Behaviors
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Red Blood Cells Internalize Extracellular DNA via Apoptotic Bodies with Clinical Relevance to Cancer Patients.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 21, 2025
Pyrotinib versus pertuzumab with trastuzumab and taxane in HER2-positive metastatic breast cancer: a Chinese multicenter real-world study.
Journal: The oncologist
Published: February 22, 2025
Energy status orchestrates YTHDF1 phase separation and tumorigenesis.
Journal: Cell reports
Published: February 14, 2025
Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 11, 2024
Exploration of the clonal evolution and construction of the tumor clonal evolution rate as a prognostic indicator in metastatic breast cancer.
Journal: BMC medicine
Published: July 11, 2024
Artificial Intelligence and Breast Cancer Management: From Data to the Clinic.
Journal: Cancer innovation
Published: July 07, 2024
Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer.
Journal: Signal transduction and targeted therapy
Published: February 26, 2024
A lactate-responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple-negative breast cancer.
Journal: Cancer innovation
Published: January 01, 2024
Lung toxicity induced by anti-HER2 antibody - drug conjugates for breast cancer.
Journal: Critical reviews in oncology/hematology
Published: October 13, 2023
Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study.
Journal: Chinese medical journal
Published: April 07, 2023
Last Updated: 09/26/2026